Skip to content

Resistant Starch as a complementary treatment for type 2 diabetes

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN10727538
Enrollment
20
Registered
2011-11-18
Start date
2010-06-01
Completion date
Unknown
Last updated
2015-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Topic: Diabetes Research Network, Primary Care Research Network for England

Interventions

Dietary Intervention, 40g/day resistant starch for weeks compared to matched placebo
Study Entry : Single Randomisation only

Sponsors

University of Surrey (UK)
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Males and Females, aged 20 - 65 years 2. Those with T2DM, that has been diagnosed for > 2 years, and 3. Are either diet / exercise controlled or on metformin treatment (or both), which has not been modified in 6 months. Target Gender: Male & Female; Upper Age Limit 65 years ; Lower Age Limit 20 years

Exclusion criteria

Exclusion criteria: 1. Those who control their diabetes by insulin or sulphonylureas 2. Those with an HbA1c >= 8.5 indicative of poor control 3. Those with certain medical conditions (for example heart disease, gastrointestinal disease, liver disease, type 1 diabetes or endocrine diseases) 4. Those know to suffer from claustrophobia or have metal implants as this would prevent Magnetic resonance spectroscopy (MRS) scanning

Design outcomes

Primary

MeasureTime frame
11. Glycaemic control 1.1. Hyperinsulinaemic clamp with stable isotopes 2. HbAc 3. Fasting glucose and insulin Measured at end of intervention

Secondary

MeasureTime frame
1. Ectopic fat distribution 1.1. Whole body magnetic resonance imaging (MRI) 2. Vascular function 2.1. Blood pressure and pulse wave analysis Measured at end of intervention

Countries

United Kingdom

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026